Corrigendum to "Heavy metal uranium affects the brain cholinergic system in rat following sub-chronic and chronic exposure" [Toxicology 261 (2009) 59-67] (DOI:10.1016/j.tox.2009.04.054);Heavy metal uranium affects the brain cholinergic system in rat following sub-chronic and chronic exposure

Toxicology

Volumn 261, Issue 1-2, 2009, Pages 59-67

  Bensoussan, Helene ^a   Grancolas, Line ^a   Dhieux Lestaevel, Bernadette ^a   Delissen, Olivia ^a   Vacher, Claire Marie ^b   Dublineau, Isabelle ^a   Voisin, Philippe ^a   Gourmelon, Patrick ^a   Taouis, Mohammed ^b   Lestaevel, Philippe ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Acetylcholine; Cerebral cortex; Hippocampus; Uranium exposure

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; HEAVY METAL; MUSCARINIC M1 RECEPTOR; NICOTINIC RECEPTOR BETA2; PROTEIN; URANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HIPPOCAMPUS; LONG TERM EXPOSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TIME; TISSUE LEVEL;

RATTUS;

EID: 66049091607     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.10.027     Document Type: Erratum

References (63)

1. Abou-Donia M.B., Goldstein L.B., Jones K.H., Abdel-Rahman A.A., Damodaran T.V., Dechkovskaia A.M., Bullman S.L., Amir B.E., and Khan W.A. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol. Sci. 60 (2001) 305-314
2. Albina M.L., Belles M., Linares V., Sanchez D.J., and Domingo J.L. Restraint stress does not enhance the uranium-induced developmental and behavioral effects in the offspring of uranium-exposed male rats. Toxicology 215 (2005) 69-79
3. ATSDR, 1999. Toxicological profile. Atlanta, US, department of health and human services. Public health services. Agency for toxic Substances and Diseases Registry.
4. Barillet S., Adam C., Palluel O., and Devaux A. Bioaccumulation, oxidative stress, and neurotoxicity in Danio rerio exposed to different isotopic compositions of uranium. Environ. Toxicol. Chem. 26 (2007) 497-505
5. Becker J.S.Z.M., Becker J.S., Pickhardt C., Damoc E., Juhacz G., Palkovits M., and Przybylski M. Determination of phosphorus-, copper-, and zinc-containing human brain proteins by LA-ICPMS and MALDI-FTICR-MS. Anal. Chem. 77 (2005) 5851-5860
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Briner W., and Murray J. Effects of short-term and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats. Neurotoxicol. Teratol. 27 (2005) 135-144
8. Bussy C., Lestaevel P., Dhieux B., Amourette C., Paquet F., Gourmelon P., and Houpert P. Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brain. Neurotoxicology 27 (2006) 245-252
9. Coccini T., Randine G., Candura S.M., Nappi R.E., Prockop L.D., and Manzo L. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring. Environ. Health Perspect. 108 (2000) 29-33
10. Craft E., Abu-Qare A., Flaherty M., Garofolo M., Rincavage H., and Abou-Donia M. Depleted and natural uranium: chemistry and toxicological effects. J. Toxicol. Environ. Health B Crit. Rev. 7 (2004) 297-317
11. Decker M.W., and Majchrzak M.J. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology (Berl.) 107 (1992) 530-534
12. Diamond G.L., Morrow P.E., Panner B.J., Gelein R.M., and Baggs R.B. Reversible uranyl fluoride nephrotoxicity in the Long Evans rat. Fundam. Appl. Toxicol. 13 (1989) 65-78
13. Domingo J.L., Llobet J.M., Tomás J.M., and Corbella J. Acute toxicity of uranium in rats and mice. Bull. Environ. Contam. Toxicol. 39 (1987) 168-174
14. Dublineau I., Grison S., Linard C., Baudelin C., Dudoignon N., Souidi M., Marquette C., Paquet F., Aigueperse J., and Gourmelon P. Short-term effects of depleted uranium on immune status in rat intestine. J. Toxicol. Environ. Health A. 69 (2006) 1613-1628
15. Ferrari R.P.P., Algeri S., Agnati L.F., and Zoli M. Subunit and region-specific decreases in nicotinic acetylcholine receptor mRNA in the aged rat brain. Neurobiol. Aging 20 (1999) 37-46
16. Finkelstein Y., Markowitz M.E., and Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Brain Res. Rev. 27 (1998) 168-176
17. Fitsanakis V.A., Erikson K.M., Garcia S.J., Evje L., Syversen T., and Aschner M. Brain accumulation of depleted uranium in rats following 3- or 6-month treatment with implanted depleted uranium pellets. Biol. Trace Elem. Res. 111 (2006) 185-197
18. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., and Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 15312-15317
19. Giacobini E.M.T., and Mussini I. Aging of cholinergic synapses in the avian iris Part I-Biochemical studies. Neurobiol. Aging 8 (1987) 123-129
20. Giovannini M.G.B.L., Kopf S.R., and Pepeu G. Acetylcholine release from the frontal cortex during exploratory activity. Brain Res. 784 (1998) 218-227
21. 3H]dopa in various regions of the brain. J. Neurochem. 13 (1966) 655-669
22. Greig N.H.U.T., Yu Q., Zhu X., Holloway H.W., Perry T., Lee B., Ingram D.K., and Lahiri D.K. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr. Med. Res. Opin. 17 (2001) 159-165
23. Gueguen Y., Souidi M., Baudelin C., Dudoignon N., Grison S., Dublineau I., Marquette C., Voisin P., Gourmelon P., and Aigueperse J. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. Arch. Toxicol. 80 (2006) 187-195
24. Hill Jr. J.A.Z.M., Bourgeois J.P., and Changeux J.P. Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit. J. Neurosci. 13 (1993) 1551-1568
25. Houpert P., Bizot J.C., Bussy C., Dhieux B., Lestaevel P., Gourmelon P., and Paquet F. Comparison of the effects of enriched uranium and 137-cesium on the behaviour of rats after chronic exposure. Int. J. Radiat. Biol. 83 (2007) 99-104
26. Houpert P., Lestaevel P., Bussy C., Paquet F., and Gourmelon P. Enriched but not depleted uranium affects central nervous system in long-term exposed rat. Neurotoxicology 26 (2005) 1015-1020
27. Hsiao B., Dweck D., and Luetje C.W. Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J. Neurosci. 21 (2001) 1848-1856
28. Huikuri P., and Salonen L. Removal of uranium from finnish groundwaters in domestic use with a strong base anion resin. J. Radioanal. Nucl. Chem. 245 (2000) 385-393
29. Janhunen S., and Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci. Biobehav. Rev. 31 (2007) 287-314
30. Kobayashi H., Yuyama A., Matsusaka N., Takeno K., and Yanagiya I. Effect of methylmercury on brain acetylcholine concentration and turnover in mice. Toxicol. Appl. Pharmacol. 54 (1980) 1-8
31. La Touche Y.D., Willis D.L., and Dawydiak O.I. Absorption and biokinetics of U in rats following an oral administration of uranyl nitrate solution. Health Phys. 53 (1987) 147-162
32. Langmead C.J., Watson J., and Reavill C. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol. Ther. 117 (2008) 232-243
33. Leggett R.W. The behavior and chemical toxicity of U in the kidney: a reassessment. Health Phys. 57 (1989) 365-383
34. Lemercier V., Millot X., Ansoborlo E., Menetrier F., Flury-Herard A., Rousselle C., and Scherrmann J.M. Study of uranium transfer across the blood-brain barrier. Radiat. Prot. Dosimetry 105 (2003) 243-245
35. Lestaevel P., Bussy C., Paquet F., Dhieux B., Clarencon D., Houpert P., and Gourmelon P. Changes in sleep-wake cycle after chronic exposure to uranium in rats. Neurotoxicol. Teratol. 27 (2005) 835-840
36. Lestaevel P., Houpert P., Bussy C., Dhieux B., Gourmelon P., and Paquet F. The brain is a target organ after acute exposure to depleted uranium. Toxicology 212 (2005) 219-226
37. Lin-Shiau S.Y., Fu W.M., and Lee C.Y. Effects of uranyl lons on neuromuscular transmission of chick biventer cervicis muscle. Arch. Int. Pharmacodyn. Ther. 241 (1979) 332-343
38. McClain D.E. Depleted uranium: a radiochemical toxicant?. Mil. Med. 167 (2002) 125-126
39. Mesulam M.M.G.A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
40. Mirzoian A., and Luetje C.W. Modulation of neuronal nicotinic acetylcholine receptors by mercury. J. Pharmacol. Exp. Ther. 302 (2002) 560-567
41. Paquet F., Houpert P., Blanchardon E., Delissen O., Maubert C., Dhieux B., Moreels A.M., Frelon S., and Gourmelon P. Accumulation and distribution of uranium in rats after chronic exposure by ingestion. Health Phys. 90 (2006) 139-147
42. Pellmar T.C., Fuciarelli A.F., Ejnik J.W., Hamilton M., Hogan J., Strocko S., Emond C., Mottaz H.M., and Landauer M.R. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol. Sci. 49 (1999) 29-39
43. Pellmar T.C., Keyser D.O., Emery C., and Hogan J.B. Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments. Neurotoxicology 20 (1999) 785-792
44. Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 4 (1978) 273-277
45. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., and Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2 (1978) 1457-1459
46. Priest N.D. Toxicity of depleted uranium. Lancet 357 (2001) 244-246
47. Raheja G., and Gill K.D. Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain. Toxicol. Ind. Health. 23 (2007) 25-37
48. Reddy G.R., Basha M.R., Devi C.B., Suresh A., Baker J.L., Shafeek A., Heinz J., and Chetty C.S. Lead induced effects on acetylcholinesterase activity in cerebellum and hippocampus of developing rat. Int. J. Dev. Neurosci. 21 (2003) 347-352
49. Ropenga A., Chapel A., Vandamme M., and Griffiths N.M. Use of reference gene expression in rat distal colon after radiation exposure: a caveat. Radiat. Res. 161 (2004) 597-602
50. Shiromani P.J., Armstrong D.M., Berkowitz A., Jeste D.V., and Gillin J.C. Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep 11 (1988) 1-16
51. Souidi M., Gueguen Y., Linard C., Dudoignon N., Grison S., Baudelin C., Marquette C., Gourmelon P., Aigueperse J., and Dublineau I. In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat. Toxicology 214 (2005) 113-122
52. 2+ movements in synaptosomes and subcellular fractions from rat brain and Torpedo electric organ. Brain Res. 323 (1984) 31-46
53. Sztajnkrycer M.D., and Otten E.J. Chemical and radiological toxicity of depleted uranium. Mil. Med. 169 (2004) 212-216
54. Taylor D.M., and Taylor S.K. Environmental uranium and human health. Rev. Environ. Health 12 (1997) 147-157
55. Takei N.N.I., and Kawamura H. Age-related decline of acetylcholine release evoked by depolarizing stimulation. Neurosci. Lett. 101 (1989) 186-196
56. Tissandie E., Gueguen Y., Lobaccaro J.M., Grandcolas L., Voisin P., Aigueperse J., Gourmelon P., and Souidi M. In vivo effects of chronic contamination with depleted uranium on vitamin D3 metabolism in rat. Biochim. Biophys. Acta 1770 (2007) 266-272
57. Tissandie E., Gueguen Y., Lobaccaro J.M., Paquet F., Aigueperse J., and Souidi M. Effects of depleted uranium after short-term exposure on vitamin D metabolism in rat. Arch. Toxicol. 80 (2006) 473-480
58. Tohgi H.U.K., Yoshimura M., Nagane Y., and Mihara M. Alterations with aging and ischemia in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human putamen. Implications for susceptibility to parkinsonism. Brain Res. 791 (1998) 186-190
59. Torda C., and Wolff H.G. Effect of blood serum from patients with myasthenia gravis on the synthesis of acetylcholine in vitro. J. Clin. Invest. 23 (1944) 649-656
60. Tsai F.S., Peng W.H., Wang W.H., Wu C.R., Hsieh C.C., Lin Y.T., Feng I.C., and Hsieh M.T. Effects of luteolin on learning acquisition in rats: involvement of the central cholinergic system. Life Sci. 80 (2007) 1692-1698
61. von Linstow Roloff E., Harbaran D., Micheau J., Platt B., and Riedel G. Dissociation of cholinergic function in spatial and procedural learning in rats. Neuroscience 146 (2007) 875-889
62. Watanabe T., Iwasaki K., Ishikane S., Naitou T., Yoshimitsu Y., Yamagata N., Ozdemir M.B., Takasaki K., Egashira N., Mishima K., and Fujiwara M. Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats. J. Pharmacol. Sci. 106 (2008) 84-91
63. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 423-450